Martin Harp - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Martin Harp's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Martin Harp
Verified
Associate Editor, Modern Retina
Cleveland
Beats
Biography
My name is Martin David Harp and I am an editor/writer that loves all things spooky, creepy and weird.
Content
By Martin Harp Verified| Ophthalmology Times Verified A cross-sectional study was conducted in the Qassim region of Saudi Arabia to assess the public’s knowledge of glaucoma and cataracts and found knowledge gaps and misconceptions among the public. The survey collected demographic data, ocular and medical history, and responses assessing knowledge of glaucoma and cataracts via an online electronic questionnaire distributed by social media platforms.
By Martin Harp Verified| Modern Retina@ Biocon Biologics announced it has reached a settlement and license agreement with Regeneron to commercialize aflibercept-jbvf (Yesafili), an interchangeable biosimilar to aflibercept, in the US. Biocon and Regeneron executed the settlement agreement to dismiss the pending appeal at the United States Court of Appeals for the Federal Circuit (USCAFC) of patent US11084865 and the pending litigation at the US District Court for the Northern District of West Virginia, Clarksburg Division.
Biocon achieves settlement agreement with Regeneron to launch aflibercept biosimilar, Yesafili in the US
By Martin Harp Verified| Ophthalmology Times Verified Biocon Biologics announced it has reached a settlement and license agreement with Regeneron to commercialize aflibercept-jbvf (Yesafili), an interchangeable biosimilar to aflibercept, in the US. Biocon and Regeneron executed the settlement agreement to dismiss the pending appeal at the United States Court of Appeals for the Federal Circuit (USCAFC) of patent US11084865 and the pending litigation at the US District Court for the Northern District of West Virginia, Clarksburg Division.
Company Info
Modern Retina